HLA-DRB1 and myeloid sarcoma: Furthermore, several studies have been conducted in the MENA countries, such as the Arabian Gulf, Iranian, Tunisian, and Saudi MS patients, and showed that HLA-DRB1 * 15:01 is high risk with MS disease [30–33].